Home > Qtrly Results > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
Quarterly Results Analysis [Jun2026]

SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹180 Cr ₹175 Cr ₹175 Cr ₹162 Cr ₹133 Cr ₹114 Cr ₹103 Cr ₹101 Cr
Expenses ₹126 Cr ₹128 Cr ₹121 Cr ₹112 Cr ₹104 Cr ₹95 Cr ₹77 Cr ₹77 Cr
Operating Income ₹54 Cr ₹47 Cr ₹54 Cr ₹50 Cr ₹29 Cr ₹19 Cr ₹26 Cr ₹23 Cr
Other Income ₹3 Cr ₹18 Cr ₹4 Cr ₹5 Cr ₹9 Cr ₹12 Cr ₹5 Cr ₹2 Cr
Interest ₹7 Cr ₹8 Cr ₹5 Cr ₹6 Cr ₹5 Cr ₹5 Cr ₹6 Cr ₹5 Cr
Depreciation ₹10 Cr ₹9 Cr ₹8 Cr ₹8 Cr ₹6 Cr ₹5 Cr ₹4 Cr ₹4 Cr
Profit Before Tax ₹39 Cr ₹47 Cr ₹45 Cr ₹41 Cr ₹26 Cr ₹21 Cr ₹20 Cr ₹16 Cr
Profit After Tax ₹30 Cr ₹37 Cr ₹34 Cr ₹30 Cr ₹21 Cr ₹18 Cr ₹16 Cr ₹13 Cr
EPS ₹6.67 ₹6.86 ₹6.88 ₹7.03 ₹4.28 ₹3.87 ₹3.73 ₹3.86
Industry Peers & Returns1W1M1Y
SENORES PHARMACEUTICALS -2.8% 11.5% 114.4%
SUN PHARMACEUTICAL INDUSTRIES -0% -4.5% 15.9%
DIVIS LABORATORIES 5.9% 16.1% 49.6%
TORRENT PHARMACEUTICALS 3% 3% 34%
CIPLA -0.4% -3.6% -11.6%
DR REDDYS LABORATORIES NA 2.8% -7.1%
MANKIND PHARMA 1.9% -6.8% -8%
LUPIN -1.3% -11.6% 11.7%
ZYDUS LIFESCIENCES 6.2% 5.9% 16.4%

SENORES PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

2.87 %

Y-o-Y

35.95 %

Quarters Revenues % Change
Jun2026 ₹180 Cr
2.87
Mar2026 ₹175 Cr
0.36
Dec2025 ₹175 Cr
7.91
Sep2025 ₹162 Cr
22.03
Jun2025 ₹133 Cr
16.07
Mar2025 ₹114 Cr
10.86
Dec2024 ₹103 Cr
2.38
Sep2024 ₹101 Cr -

SENORES PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

13.20 %

Y-o-Y

87.12 %

Quarters Operating Profit % Change
Jun2026 ₹54 Cr
13.20
Mar2026 ₹47 Cr
-12.06
Dec2025 ₹54 Cr
9.07
Sep2025 ₹50 Cr
72.33
Jun2025 ₹29 Cr
47.79
Mar2025 ₹19 Cr
-24.30
Dec2024 ₹26 Cr
10.45
Sep2024 ₹23 Cr -
Operating Margins
Q-o-Q

10.03 %

Y-o-Y

37.66 %

Quarters Operating Margin% % Change
Jun2026 29.83%
10.03
Mar2026 27.11%
-12.35
Dec2025 30.93%
1.05
Sep2025 30.61%
41.26
Jun2025 21.67%
27.32
Mar2025 17.02%
-31.73
Dec2024 24.93%
7.92
Sep2024 23.1% -

SENORES PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-16.96 %

Y-o-Y

43.77 %

Quarters Profit After Tax % Change
Jun2026 ₹30 Cr
-16.96
Mar2026 ₹37 Cr
9.20
Dec2025 ₹34 Cr
11.49
Sep2025 ₹30 Cr
42.21
Jun2025 ₹21 Cr
17.86
Mar2025 ₹18 Cr
9.44
Dec2024 ₹16 Cr
25.92
Sep2024 ₹13 Cr -
PAT Margins
Q-o-Q

-19.25 %

Y-o-Y

5.76 %

Quarters PAT Margin(%) % Change
Jun2026 16.9 %
-19.25
Mar2026 20.93 %
8.78
Dec2025 19.24 %
3.33
Sep2025 18.62 %
16.52
Jun2025 15.98 %
1.59
Mar2025 15.73 %
-1.32
Dec2024 15.94 %
22.99
Sep2024 12.96 % -

SENORES PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-2.77 %

Y-o-Y

55.84 %

Quarters EPS % Change
Jun2026 ₹6.67
-2.77
Mar2026 ₹6.86
-0.29
Dec2025 ₹6.88
-2.13
Sep2025 ₹7.03
64.25
Jun2025 ₹4.28
10.59
Mar2025 ₹3.87
3.75
Dec2024 ₹3.73
-3.37
Sep2024 ₹3.86 -

You may also like the below Video Courses